IO Biotech Q3 2025 Earnings EPS Beats Estimates by 6067 as Narrowing Losses Highlight Cost Discipline BK Q1 2026 Earnings EPS Surpasses Estimates by 133 Revenue Details Not Disclosed NextDecade Corporation Q1 2026 Earnings Narrower Loss Drives Modest Share Gain CIFR Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Rises 209 CAAP Q1 2026 Earnings EPS Misses Consensus by 75 as Operating Costs Weigh